Improving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support
1 other identifier
interventional
1,200
1 country
1
Brief Summary
The goal of this project is to establish the technical feasibility of a scalable, integrated platform to improve patient informed decision-making and increase vaccine uptake and to evaluate the effectiveness of the integrated platform to improve vaccine uptake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2024
CompletedFirst Posted
Study publicly available on registry
July 1, 2024
CompletedStudy Start
First participant enrolled
June 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedJuly 20, 2025
July 1, 2025
11 months
June 26, 2024
July 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Vaccination rate
Proportion of vaccines due that are administered at the index appointment
Baseline
Secondary Outcomes (3)
Days undervaccinated
Through 24 months of age
Patient Adoption as assessed by proportion of successful texts sent
Up to one year
Provider Adoption as assessed by proportion of orders opened
Up to one year
Study Arms (4)
Patient- and Provider-Facing CDS
EXPERIMENTALParents of patients with odd birthdates (e.g. April 13) and vaccines due at the index appointment who also have a MYchart account will receive a text message directing the parent to the LTS server with integration into the provider workflow
Patient-Facing CDS Only
EXPERIMENTALAmong patients without a MYchart account, those with odd birthdates will receive a link to the LTS website (patient-facing CDS) but no integration into the provider workflow.
Control (MYchart account)
PLACEBO COMPARATORPatients with an even birthdate (e.g. April 14) who have a MYchart account will receive a regular text message and e-mail appointment reminder with a vaccine primer (e.g. "Vaccines are due and reserved for the participant's child"), but no patient- or provider-facing CDS.
Control (no MYchart account)
PLACEBO COMPARATORAs in the other control group, those without a MYchart account and an even birthdate (e.g. April 14) will receive a text message and e-mail appointment reminder with a vaccine primer but no patient- or provider-facing CDS.
Interventions
LetsTalkShots is a website which provides patients/parents with tailored videos addressing vaccine concerns.
The provider-facing CDS component will propagate patient concerns obtained from LetsTalkShots (and the appropriate talking points to address the talking points) into the electronic health record (EHR) for the provider at the point of care.
The regular text message and e-mail appointment reminder includes a vaccine primer (e.g. "Vaccines are due and reserved for the participant's child"), but no patient- or provider-facing CDS.
Eligibility Criteria
You may qualify if:
- Patient has an upcoming appointment in 2 business days at Children's Healthcare of Atlanta Hughes Spalding Primary Care Clinic.
- A valid mobile phone number or e-mail address is available in the EHR as of 2 business days prior to the appointment date.
- Phase 1: COVID-19 Vaccine only:
- Due for a COVID-19 vaccine based on Epic Systems© COVID-19 vaccine health maintenance topic.
- Phase 2: All Vaccines:
- Due for any vaccines based on Epic Systems© implementation using health maintenance topics of the Centers for Disease Control CDS for Immunization (CDSi) specifications.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johns Hopkins Bloomberg School of Public Healthlead
- Children's Healthcare of Atlantacollaborator
- Emory Universitycollaborator
- Merck & Companycollaborator
Study Sites (1)
Children's Healthcare of Atlanta Hughes Spalding Primary Care Clinic
Atlanta, Georgia, 30303, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel Salmon, PhD
Johns Hopkins Bloomberg School of Public Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2024
First Posted
July 1, 2024
Study Start
June 11, 2025
Primary Completion
May 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
July 20, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share